Completed NA INTERVENTIONAL 4-arm NCT04555447

Gastrointestinal Tolerability to Agavins and Impact on Host-gut Microbiota-metabolism Interactions Modulation

Gastrointestinal Tolerability to Increasing Doses of Agavins and Impact on Gut Microbiota, Fecal Metabolites, and Metabolic Biomarkers in Healthy and Obese Subjects

Sponsor: Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato

Conditions Healthy Obesity

Interventions Agavins (prebiotic fiber) Placebo

Updated 4 times since 2020 Last updated: Sep 14, 2020 Started: Mar 22, 2019 Primary completion: Sep 7, 2019 Completion: Sep 7, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy and Obesity, this trial is completed. The trial is conducted by Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato and has accumulated 4 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato
Centro de Estudios Cardiometabólicos S.C. (CESCAM)
Inulina y Miel de Agave S.A. de C.V. (IMAG)

Data source: Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Irapuato, Mexico
• Mexico City, Mexico